Castro M G, Morrison E, Tomasec P, Linton E A, Lowenstein P R
Laboratory of Cellular and Molecular Neurobiology, Department of Physiology, University of Wales College of Cardiff, PO Box 911, Museum Avenue, Cardiff CF1 3US, UK.
Cell Tissue Res. 1995 Dec;282(3):367-76. doi: 10.1007/BF00318869.
Human autoantibodies and corticotrophin-releasing hormone (CRH)-specific antibodies have been used in a double-labelling immunofluorescence technique to demonstrate that immunoreactive CRH structures are co-localised with immunostaining produced by double stranded DNA-specific human autoantibodies within the nucleus of cultured ovarian cells of Chinese hamsters (CHO-K1). This co-localisation was confirmed using confocal microscopy. A metabolic labelling technique was used to investigate the role of the cytoskeleton in mediating nuclear translocation of proCRH within stably transfected CHO-K1 cells and showed that microtubule and actin disrupting agents had no effect upon the nuclear translocation of proCRH. These results, therefore, suggest that nuclear translocation of proCRH is not affected by drugs which disrupt the cytoskeleton and, consequently, modify the diameter of the nuclear pores.
人自身抗体和促肾上腺皮质激素释放激素(CRH)特异性抗体已被用于双标记免疫荧光技术,以证明免疫反应性CRH结构与双链DNA特异性人自身抗体在中华仓鼠(CHO-K1)培养的卵巢细胞核内产生的免疫染色共定位。使用共聚焦显微镜证实了这种共定位。采用代谢标记技术研究细胞骨架在稳定转染的CHO-K1细胞中介导proCRH核转位的作用,结果表明微管和肌动蛋白破坏剂对proCRH的核转位没有影响。因此,这些结果表明,proCRH的核转位不受破坏细胞骨架并因此改变核孔直径的药物的影响。